Manuela Rabaglio

发表论文 162 篇 · 总被引 7787 次 · h-index 35

代表论文

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet Oncology · 被引 130)
High impact of chemotherapy on ovarian reserve in breast cancer survivors of reproductive age: A systematic review and meta-analysis (2025 · The Breast · 被引 13)
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial (2024 · Cancer Chemotherapy and Pharmacology · 被引 7)
LBA39 Final overall survival (OS) results from the randomized double-blind phase III AtTEnd/ENGOT-EN7 trial evaluating atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer (2025 · Annals of Oncology · 被引 6)
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer (2024 · The Breast · 被引 6)
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial (2025 · Journal of Gynecologic Oncology · 被引 5)